Wockhardt Ltd.

₹1,211.3

-87.3 (-6.7%)

WOCKPHARMA Share Price

Pharmaceuticals & Biotechnology

As on March 13, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 19,751 Cr

P/E Ratio-417.52

Dividend YieldN/A

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	1,282.38	Bearish
10-DMA	1,297.89	Bearish
20-DMA	1,341.75	Bearish
50-DMA	1,374.44	Bearish
100-DMA	1,364.26	Bearish
200-DMA	1,465.77	Bearish

Historical Performance

1 Year

-6.2%

3 Years

565%

5 Years

170.2%

10 Years

35.2%

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Net Sales	30,120	27,980	26,510	32,300	27,080
Total Expenditure	26,190	27,590	25,500	29,320	27,710
Other Income	620	830	1,220	200	1,320
Operating Profit	4,550	1,220	2,230	3,180	690
Interest	2,540	3,050	3,020	2,990	2,490
Depreciation	2,170	2,230	2,510	2,470	2,460
Profit Before Tax	-160	-4,200	-6,240	-4,110	-5,680
Consolidated Net Profit	-470	-4,630	-5,590	-2,440	6,860
Adjusted EPS	-3	-30	-39	-17	57

Compounded Sales Growth

10 Years:-7.6

5 Years:1.2

3 Years:-1.4

TTM:1.5

Compounded Profit Growth

10 Years:-47.4

5 Years:-7.5

3 Years:-28.1

TTM:-36.7

Stock Price CAGR

10 Years:3.2

5 Years:22.9

3 Years:92

TTM:-6.3

Return on Equity

10 Years:20.9

5 Years:57.5

3 Years:-38.8

last year:-2.9

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Share Capital	810	770	720	720	550
Total Reserves	42,600	32,690	32,660	37,590	32,930
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	8,870	6,170	-220	2,610	4,960
Other Current Liabilities	8,870	11,440	11,720	11,970	12,300
Short Term Borrowings	4,960	8,320	13,300	10,340	10,660
Total Liabilities	75,860	70,700	70,750	76,700	73,760
Capital Work in Progress	5,130	4,340	4,140	3,890	6,030
Long Term Loans & Advances	2,460	2,660	2,690	2,590	2,280
Currents Investments	4,220	---	---	---	---
Short Term Loans and Advances	4,660	2,860	3,350	3,520	2,720
Total Current Assets	24,650	20,730	19,140	24,450	22,810
Total Assets	75,860	70,700	70,750	76,700	73,760
Adjusted Book Value	268	217	232	266	280

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a low PE of -417.52, which may indicate undervaluation or subdued growth expectations.
Over the last three years, the stock delivered a strong 3-year price CAGR of 92.0%, indicating sustained price appreciation.
The stock carries a high beta of 1.3, implying higher volatility and elevated risk.
In the last financial year, the company reported an EBITDA of ₹4550 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹30120 million, indicating a large and established business.

Investment Calculator

Investment Amount:

₹

Investment Amount: ₹ 1000000

Current Value: ₹ 939137.9

No. of Shares: 775 (Approx)

Performance:-6.1%

P/L: ₹-60862.1

NIFTY Performance: 3.4%

1 day Top Gainers